Zobrazeno 1 - 10 of 1 691 pro vyhledávání: '"Ebeling, F."'
2
Akademický článek
An assessment of the Henssge method for forensic death time estimation in the early post-mortem interval.
Autor: Heinrich F; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.; Centre for Data and Statistical Science for Health, London School of Hygiene and Tropical Medicine, London, UK., Rimkus-Ebeling F; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dietz E; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Raupach T; Institute for Medical Education, University Hospital Bonn, Bonn, Germany., Ondruschka B; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Anders-Lohner S; Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. s.anders-lohner@uke.de.
Publikováno v: International journal of legal medicine [Int J Legal Med] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.
Zobrazit plný text záznamu
3
Akademický článek
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Autor: Tobiasson M; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Pandzic T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Illman J; Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland., Nilsson L; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Lund, Sweden., Weström S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ejerblad E; Unit of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Olesen G; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Björklund A; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Stockholm, Sweden., Olsnes Kittang A; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Werlenius O; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Lorentz F; Department of Hematology, Norrlands University Hospital, Umeå, Sweden., Rasmussen B; Department of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Cammenga J; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Lund, Sweden.; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden., Weber D; Department of Hematology, Odense University Hospital, Odense, Denmark., Lindholm C; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Wiggh J; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Dimitriou M; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Moen AE; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Yip Lundström L; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden., von Bahr L; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Baltzer-Sollander K; Department of Genetics, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Jädersten M; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Kytölä S; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Walldin G; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Stockholm, Sweden., Groenbaek K; Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark., Mielke S; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Department of Laboratory Medicine, Karolinska Insititutet, Stockholm, Sweden., Jacobsen SEW; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden., Ebeling F; Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland., Cavelier L; Department of Genetics, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Smidstrup Friis L; Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark., Dybedal I; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Hellström-Lindberg E; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 20; Vol. 42 (12), pp. 1378-1390. Date of Electronic Publication: 2024 Jan 17.
Zobrazit plný text záznamu
5
Editorial & Opinion
Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome.
Autor: Illman J; Department of Internal Medicine, Porvoo Hospital, Helsinki and Uusimaa Hospital District, Porvoo, Finland., Kytölä S; Laboratory of Genetics, HUS Diagnostic Center, Helsinki University Hospital and Helsinki University, Helsinki, Finland., Myllymäki M; Helsinki University Hospital, Comprehensive Cancer Center, Division of Hematology, Helsinki, Finland; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland., Ebeling F; Helsinki University Hospital, Comprehensive Cancer Center, Division of Hematology, Helsinki, Finland.
Publikováno v: Haematologica [Haematologica] 2023 Jul 01; Vol. 108 (7), pp. 1951-1956. Date of Electronic Publication: 2023 Jul 01.
Zobrazit plný text záznamu
6
Report
Sequential high-sensitivity mutational and chimerism analyses predict responses to post-transplant salvage therapies in MDS.
Autor: Ebeling F; Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Haartmaninkatu 4, 00290, Helsinki, Finland. ext-freja.ebeling@hus.fi., Illman J; Department of Internal Medicine, Porvoo Hospital, Helsinki and Uusimaa Hospital District, Porvoo, Finland., Kankainen M; Laboratory of Genetics, HUS Diagnostic Center, Helsinki and Uusimaa Hospital District, Helsinki, Finland.; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Kontro M; Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Haartmaninkatu 4, 00290, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland., Partanen A; Department of Medicine, Kuopio University Hospital, Kuopio, Finland., Sahlstedt L; Division of Hematology, Stem Cell Transplantation Unit, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland., Myllymäki M; Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Haartmaninkatu 4, 00290, Helsinki, Finland.; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland., Niittyvuopio R; Division of Hematology, Stem Cell Transplantation Unit, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland., Kytölä S; Laboratory of Genetics, HUS Diagnostic Center, Helsinki and Uusimaa Hospital District, Helsinki, Finland.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2023 Jan; Vol. 58 (1), pp. 100-102. Date of Electronic Publication: 2022 Oct 17.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Viral markers and use of factor products among Finnish patients with bleeding disorders.
Autor: Ebeling, F., Rasi, V., Laitinen, H., Krusius, T.
Publikováno v: Haemophilia. Jan2001, Vol. 7 Issue 1, p42. 5p.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Report
"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
Autor: Rasmussen B; School of Medical Sciences, Örebro University, Örebro, Sweden., Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Bernard E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nilsson L; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Tobiasson M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Jädersten M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Garelius H; Section for Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Dybedal I; Department of Hematology, Oslo University Hospital, Oslo, Norway., Grønbaek K; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Ejerblad E; Department of Medical Science, Section of Hematology, Uppsala University, Uppsala, Sweden., Lorenz F; Department of Medical Biosciences, Umeå University, Umeå, Sweden., Flogegård M; Department of Internal Medicine, Falun General Hospital, Falun, Sweden., Marcher CW; Department of Hematology, Odense University Hospital, Odense, Denmark., Öster Fernström A; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden., Cavelier L; Clinical Genomics Facility, Uppsala, Science for Life Laboratory IGP, Rudbeck Laboratory, Uppsala University and Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Papaemmanuil E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ebeling F; Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland., Kittang AO; Division for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Nørgaard JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Saft L; Department of Clinical Pathology, Division of Hematopathology, Karolinska University Hospital and Institute, Solna, Stockholm, Sweden., Möllgård L; Section for Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Hellström-Lindberg E; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. eva.hellstrom-lindberg@ki.se.
Publikováno v: Leukemia [Leukemia] 2022 May; Vol. 36 (5), pp. 1436-1439. Date of Electronic Publication: 2022 Mar 11.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje